Skip to main content

Table 3 Factors predictive of MACE by Cox regression Model

From: Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention

 

Univariate

 

Multivariate

 

Variable

HR

CI

P value

HR

CI

P value

Baseline characteristics

Age, years

1.03

1.01-1.10

0.02

1.01

0.96-1.06

0.81

Male

1.31

0.42-4.09

0.64

   

BMI

0.92

0.81-1.05

0.23

   

Hypertension

0.61

0.14-2.67

0.51

   

Smoking

1.04

0.39-2.79

0.93

   

Insulin therapy

1.61

0.37-7.12

0.53

   

Creatinine

1.01

1.00-1.02

0.06

1.01

0.98-1.02

0.12

HbA1c

1.04

0.72-1.50

0.85

   

Total cholesterol

0.84

0.45-1.57

0.59

   

Triglyceride

0.93

0.63-1.39

0.73

   

HDL

0.34

0.03-4.20

0.40

   

LDL

0.90

0.40-1.98

0.79

   

Triple vessel disease

3.03

0.83-11.07

0.09

1.37

0.16-11.51

0.77

Prior myocardial infarction

1.45

0.54-4.08

0.45

   

Prior PCI

1.67

0.62-4.49

0.31

   

Drug eluting stent

0.67

0.25-1.82

0.44

   

Impaired LVEF < 50%

1.79

0.41-7.87

0.44

   

Medications

ISMN

3.88

1.25-12.0

0.02

3.09

1.19-10.21

0.04

Beta blocker

2.06

0.27-15.67

0.49

   

CCB

1.58

0.45-5.59

0.48

   

Statin

3.60

0.73-17.92

0.12

   

ACEI/ARB

1.28

0.36-4.53

0.70

   

Aldosterone blocker,

0.40

0.28-8.21

0.83

   
  1. Abbreviation similar to Tables 1 and 2.